Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
- PMID: 17136094
- DOI: 10.1038/nature05327
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Abstract
Early tumorigenesis is associated with the engagement of the DNA-damage checkpoint response (DDR). Cell proliferation and transformation induced by oncogene activation are restrained by cellular senescence. It is unclear whether DDR activation and oncogene-induced senescence (OIS) are causally linked. Here we show that senescence, triggered by the expression of an activated oncogene (H-RasV12) in normal human cells, is a consequence of the activation of a robust DDR. Experimental inactivation of DDR abrogates OIS and promotes cell transformation. DDR and OIS are established after a hyper-replicative phase occurring immediately after oncogene expression. Senescent cells arrest with partly replicated DNA and with DNA replication origins having fired multiple times. In vivo DNA labelling and molecular DNA combing reveal that oncogene activation leads to augmented numbers of active replicons and to alterations in DNA replication fork progression. We also show that oncogene expression does not trigger a DDR in the absence of DNA replication. Last, we show that oncogene activation is associated with DDR activation in a mouse model in vivo. We propose that OIS results from the enforcement of a DDR triggered by oncogene-induced DNA hyper-replication.
Similar articles
-
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints.Nature. 2006 Nov 30;444(7119):633-7. doi: 10.1038/nature05268. Nature. 2006. PMID: 17136093
-
Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.Nat Cell Biol. 2007 May;9(5):493-505. doi: 10.1038/ncb1567. Epub 2007 Apr 22. Nat Cell Biol. 2007. PMID: 17450133
-
DNA damage signalling guards against activated oncogenes and tumour progression.Oncogene. 2007 Dec 10;26(56):7773-9. doi: 10.1038/sj.onc.1210881. Oncogene. 2007. PMID: 18066090 Review.
-
Oncogene-induced cellular senescence.Adv Anat Pathol. 2010 Jan;17(1):42-8. doi: 10.1097/PAP.0b013e3181c66f4e. Adv Anat Pathol. 2010. PMID: 20032638 Review.
-
Retinoblastoma loss modulates DNA damage response favoring tumor progression.PLoS One. 2008;3(11):e3632. doi: 10.1371/journal.pone.0003632. Epub 2008 Nov 5. PLoS One. 2008. PMID: 18985151 Free PMC article.
Cited by
-
BRIT1 regulates p53 stability and functions as a tumor suppressor in breast cancer.Carcinogenesis. 2013 Oct;34(10):2271-80. doi: 10.1093/carcin/bgt190. Epub 2013 Jun 1. Carcinogenesis. 2013. PMID: 23729656 Free PMC article.
-
The potential for chemical mixtures from the environment to enable the cancer hallmark of sustained proliferative signalling.Carcinogenesis. 2015 Jun;36 Suppl 1(Suppl 1):S38-60. doi: 10.1093/carcin/bgv030. Carcinogenesis. 2015. PMID: 26106143 Free PMC article. Review.
-
Cyclin-dependent kinase regulates the length of S phase through TICRR/TRESLIN phosphorylation.Genes Dev. 2015 Mar 1;29(5):555-66. doi: 10.1101/gad.246827.114. Genes Dev. 2015. PMID: 25737283 Free PMC article.
-
Genome integrity and inflammation in the nervous system.DNA Repair (Amst). 2022 Nov;119:103406. doi: 10.1016/j.dnarep.2022.103406. Epub 2022 Sep 14. DNA Repair (Amst). 2022. PMID: 36148701 Free PMC article. Review.
-
Back to the origin: reconsidering replication, transcription, epigenetics, and cell cycle control.Genes Cancer. 2012 Nov;3(11-12):678-96. doi: 10.1177/1947601912474891. Genes Cancer. 2012. PMID: 23634256 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources